Literature DB >> 19192719

Neutral pH hydrogen-enriched electrolyzed water achieves tumor-preferential clonal growth inhibition over normal cells and tumor invasion inhibition concurrently with intracellular oxidant repression.

Yasukazu Saitoh1, Hajime Okayasu, Li Xiao, Yoshikazu Harata, Nobuhiko Miwa.   

Abstract

The properties and effects of neutral pH hydrogen-enriched electrolyzed water (NHE water) on tumor cells were examined. NHE water diminished hydroxyl radicals as demonstrated by ESR in a cell-free system. Human tongue carcinoma cells HSC-4 were inhibited for either colony formation efficiencies or colony sizes by NHE water without significant inhibition to normal human tongue epithelial-like cells DOK. Furthermore, NHE water caused growth inhibition, cell degeneration, and inhibition of invasion through the reconstituted basement membrane to human fibrosarcoma cells HT-1080. Intracellular oxidants such as hydroperoxides and hydrogen peroxides were scavenged in HSC-4 or HT-1080 cells by NHE water. In the human oral cavity, a dissolved hydrogen concentrations (DH) of NHE water was drastically declined from 1.1 to 0.5 ppm, but settled to 0.3-0.4 ppm until 180 s, upon static holding without gargling. Thus, NHE water was shown to achieve tumor-preferential growth inhibition and tumor invasion together with scavenging of intracellular oxidants, and is expected as a preventive material against tumor progression and invasion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19192719     DOI: 10.3727/096504008786991620

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  23 in total

1.  Effect of hydrogen injected subcutaneously on testicular tissues of rats exposed to cigarette smoke.

Authors:  Song Chen; Wei Jiang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 2.  Anti-inflammatory and antitumor action of hydrogen via reactive oxygen species.

Authors:  Ye Yang; Yaping Zhu; Xiaowei Xi
Journal:  Oncol Lett       Date:  2018-06-26       Impact factor: 2.967

Review 3.  Hydrogen treatment: a novel option in liver diseases.

Authors:  Jian Shi; Brittany Duncan; Xuyuan Kuang
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

4.  Molecular hydrogen suppresses Porphyromonas gingivalis lipopolysaccharide-induced increases in interleukin-1 alpha and interleukin-6 secretion in human gingival cells.

Authors:  Yasukazu Saitoh; Nene Yonekura; Daigo Matsuoka; Akira Matsumoto
Journal:  Mol Cell Biochem       Date:  2021-09-17       Impact factor: 3.396

5.  Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study.

Authors:  Hirohisa Ono; Yoji Nishijima; Naoto Adachi; Shigekuni Tachibana; Shiroh Chitoku; Shigeo Mukaihara; Masaki Sakamoto; Yohei Kudo; Jun Nakazawa; Kumi Kaneko; Hiroshi Nawashiro
Journal:  Med Gas Res       Date:  2011-06-07

6.  The 2011 Medical Molecular Hydrogen Symposium: An inaugural symposium of the journal Medical Gas Research.

Authors:  Shigeo Ohta; Atsunori Nakao; Kinji Ohno
Journal:  Med Gas Res       Date:  2011-06-07

Review 7.  Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases.

Authors:  Kinji Ohno; Mikako Ito; Masatoshi Ichihara; Masafumi Ito
Journal:  Oxid Med Cell Longev       Date:  2012-06-08       Impact factor: 6.543

8.  Hydrogen water intake via tube-feeding for patients with pressure ulcer and its reconstructive effects on normal human skin cells in vitro.

Authors:  Qiang Li; Shinya Kato; Daigo Matsuoka; Hiroshi Tanaka; Nobuhiko Miwa
Journal:  Med Gas Res       Date:  2013-09-10

9.  The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance.

Authors:  Brandon J Dixon; Jiping Tang; John H Zhang
Journal:  Med Gas Res       Date:  2013-05-16

10.  Dose-dependent inhibition of gastric injury by hydrogen in alkaline electrolyzed drinking water.

Authors:  Jinling Xue; Guodong Shang; Yoshinori Tanaka; Yasuhiro Saihara; Lingyan Hou; Natalia Velasquez; Wenjun Liu; Yun Lu
Journal:  BMC Complement Altern Med       Date:  2014-03-03       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.